

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GMP metabolic process (GO:0046037) | 9.91681587 |
| 2 | retinal rod cell development (GO:0046548) | 9.06710796 |
| 3 | * visual perception (GO:0007601) | 8.77173639 |
| 4 | * sensory perception of light stimulus (GO:0050953) | 8.66959748 |
| 5 | * positive regulation of guanylate cyclase activity (GO:0031284) | 7.56483534 |
| 6 | * cellular response to light stimulus (GO:0071482) | 7.30347155 |
| 7 | photoreceptor cell differentiation (GO:0046530) | 7.19466147 |
| 8 | eye photoreceptor cell differentiation (GO:0001754) | 7.19466147 |
| 9 | * detection of external stimulus (GO:0009581) | 7.16959664 |
| 10 | * detection of abiotic stimulus (GO:0009582) | 7.02801279 |
| 11 | * regulation of guanylate cyclase activity (GO:0031282) | 6.75531588 |
| 12 | retina development in camera-type eye (GO:0060041) | 6.54245156 |
| 13 | detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580) | 6.46144573 |
| 14 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 5.68122701 |
| 15 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 5.36572504 |
| 16 | * regulation of cGMP metabolic process (GO:0030823) | 5.30370413 |
| 17 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 5.27627362 |
| 18 | cell morphogenesis involved in neuron differentiation (GO:0048667) | 5.08171930 |
| 19 | negative regulation of cardiac muscle hypertrophy (GO:0010614) | 4.95687962 |
| 20 | nonmotile primary cilium assembly (GO:0035058) | 4.82567884 |
| 21 | * cellular response to radiation (GO:0071478) | 4.68583225 |
| 22 | adaptation of signaling pathway (GO:0023058) | 4.59012515 |
| 23 | regulation of voltage-gated calcium channel activity (GO:1901385) | 4.45846445 |
| 24 | negative regulation of muscle hypertrophy (GO:0014741) | 4.40557156 |
| 25 | * regulation of G-protein coupled receptor protein signaling pathway (GO:0008277) | 4.27812377 |
| 26 | * positive regulation of cGMP biosynthetic process (GO:0030828) | 4.24151253 |
| 27 | response to electrical stimulus (GO:0051602) | 4.23235959 |
| 28 | transepithelial transport (GO:0070633) | 4.12604129 |
| 29 | protein prenylation (GO:0018342) | 4.11107698 |
| 30 | prenylation (GO:0097354) | 4.11107698 |
| 31 | * sensory perception (GO:0007600) | 4.10521019 |
| 32 | short-term memory (GO:0007614) | 4.09311352 |
| 33 | fat-soluble vitamin metabolic process (GO:0006775) | 4.00224066 |
| 34 | sensory perception of taste (GO:0050909) | 3.96728196 |
| 35 | * regulation of cGMP biosynthetic process (GO:0030826) | 3.96081420 |
| 36 | regulation of clathrin-mediated endocytosis (GO:2000369) | 3.92686435 |
| 37 | * response to light stimulus (GO:0009416) | 3.92387928 |
| 38 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 3.88785015 |
| 39 | regulation of penile erection (GO:0060405) | 3.88084657 |
| 40 | estrogen biosynthetic process (GO:0006703) | 3.82333548 |
| 41 | behavioral response to ethanol (GO:0048149) | 3.81505922 |
| 42 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 3.81323766 |
| 43 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 3.81323766 |
| 44 | negative regulation of heart growth (GO:0061117) | 3.79796049 |
| 45 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 3.79796049 |
| 46 | chemosensory behavior (GO:0007635) | 3.78355028 |
| 47 | neuron development (GO:0048666) | 3.72963326 |
| 48 | retina homeostasis (GO:0001895) | 3.72756317 |
| 49 | cellular response to ATP (GO:0071318) | 3.70641419 |
| 50 | * positive regulation of cGMP metabolic process (GO:0030825) | 3.69060976 |
| 51 | detection of chemical stimulus involved in sensory perception of taste (GO:0050912) | 3.68572104 |
| 52 | retinal metabolic process (GO:0042574) | 3.68167279 |
| 53 | response to histamine (GO:0034776) | 3.62958603 |
| 54 | retina layer formation (GO:0010842) | 3.50469871 |
| 55 | positive regulation of G-protein coupled receptor protein signaling pathway (GO:0045745) | 3.48265992 |
| 56 | keratan sulfate catabolic process (GO:0042340) | 3.45778462 |
| 57 | positive regulation of sodium ion transmembrane transport (GO:1902307) | 3.40129648 |
| 58 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.39360548 |
| 59 | detection of chemical stimulus involved in sensory perception (GO:0050907) | 3.36918054 |
| 60 | regulation of skeletal muscle contraction (GO:0014819) | 3.32618951 |
| 61 | positive regulation of neurotransmitter transport (GO:0051590) | 3.31650236 |
| 62 | positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742) | 3.31472326 |
| 63 | negative regulation of receptor-mediated endocytosis (GO:0048261) | 3.31285192 |
| 64 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 3.26556676 |
| 65 | acrosome reaction (GO:0007340) | 3.23967187 |
| 66 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 3.19097382 |
| 67 | membrane hyperpolarization (GO:0060081) | 3.18690056 |
| 68 | protein localization to synapse (GO:0035418) | 3.17625704 |
| 69 | regulation of cytokine production involved in inflammatory response (GO:1900015) | 3.13722524 |
| 70 | retinoid metabolic process (GO:0001523) | 3.13049366 |
| 71 | positive regulation of ERBB signaling pathway (GO:1901186) | 3.09825317 |
| 72 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.06486666 |
| 73 | regulation of heat generation (GO:0031650) | 3.04828829 |
| 74 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.03811788 |
| 75 | positive regulation of heat generation (GO:0031652) | 3.00724875 |
| 76 | arachidonic acid secretion (GO:0050482) | 2.97118926 |
| 77 | icosanoid secretion (GO:0032309) | 2.97118926 |
| 78 | CDP-diacylglycerol metabolic process (GO:0046341) | 2.96387185 |
| 79 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.95193643 |
| 80 | behavioral response to cocaine (GO:0048148) | 2.94686413 |
| 81 | diterpenoid metabolic process (GO:0016101) | 2.89747182 |
| 82 | negative regulation of cation channel activity (GO:2001258) | 2.88335565 |
| 83 | synaptic transmission, dopaminergic (GO:0001963) | 2.86113127 |
| 84 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.85197910 |
| 85 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.85197910 |
| 86 | negative regulation of cardiac muscle tissue development (GO:0055026) | 2.82216058 |
| 87 | piRNA metabolic process (GO:0034587) | 2.75576442 |
| 88 | phospholipid translocation (GO:0045332) | 2.73802987 |
| 89 | lipid translocation (GO:0034204) | 2.73802987 |
| 90 | * response to radiation (GO:0009314) | 2.70364936 |
| 91 | dopamine receptor signaling pathway (GO:0007212) | 2.68546172 |
| 92 | retinol metabolic process (GO:0042572) | 2.68203544 |
| 93 | neutrophil activation involved in immune response (GO:0002283) | 2.67605002 |
| 94 | purinergic receptor signaling pathway (GO:0035587) | 2.67341879 |
| 95 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 2.66561477 |
| 96 | indole-containing compound catabolic process (GO:0042436) | 2.66332771 |
| 97 | indolalkylamine catabolic process (GO:0046218) | 2.66332771 |
| 98 | tryptophan catabolic process (GO:0006569) | 2.66332771 |
| 99 | terpenoid metabolic process (GO:0006721) | 2.65327908 |
| 100 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.65213287 |
| 101 | regulation of neurotransmitter uptake (GO:0051580) | 2.62984052 |
| 102 | protein heterotetramerization (GO:0051290) | 2.58717416 |
| 103 | regulation of catecholamine metabolic process (GO:0042069) | 2.57359175 |
| 104 | regulation of dopamine metabolic process (GO:0042053) | 2.57359175 |
| 105 | synaptic vesicle maturation (GO:0016188) | 2.55673988 |
| 106 | behavioral response to nicotine (GO:0035095) | 2.49653739 |
| 107 | post-embryonic morphogenesis (GO:0009886) | 2.46304361 |
| 108 | mitotic cell cycle arrest (GO:0071850) | 2.42738914 |
| 109 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.42438342 |
| 110 | response to hydroperoxide (GO:0033194) | 2.42007858 |
| 111 | lipoprotein transport (GO:0042953) | 2.41285790 |
| 112 | cell wall macromolecule catabolic process (GO:0016998) | 2.40353860 |
| 113 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.40274393 |
| 114 | fatty acid derivative transport (GO:1901571) | 2.38548204 |
| 115 | icosanoid transport (GO:0071715) | 2.38548204 |
| 116 | axoneme assembly (GO:0035082) | 2.37819194 |
| 117 | indolalkylamine metabolic process (GO:0006586) | 2.37166845 |
| 118 | positive regulation of membrane potential (GO:0045838) | 2.36661076 |
| 119 | sensory perception of chemical stimulus (GO:0007606) | 2.36544051 |
| 120 | regulation of cardiac muscle hypertrophy (GO:0010611) | 2.36209676 |
| 121 | * cellular response to abiotic stimulus (GO:0071214) | 2.35743325 |
| 122 | positive regulation of vasculogenesis (GO:2001214) | 2.35564245 |
| 123 | DNA methylation involved in gamete generation (GO:0043046) | 2.33365595 |
| 124 | adenosine receptor signaling pathway (GO:0001973) | 2.31343938 |
| 125 | mature B cell differentiation involved in immune response (GO:0002313) | 2.31120236 |
| 126 | lens fiber cell differentiation (GO:0070306) | 2.29798639 |
| 127 | negative regulation of mast cell activation (GO:0033004) | 2.27436820 |
| 128 | regulation of muscle hypertrophy (GO:0014743) | 2.25401166 |
| 129 | sialylation (GO:0097503) | 2.25023000 |
| 130 | phosphatidylethanolamine biosynthetic process (GO:0006646) | 2.23517085 |
| 131 | response to ATP (GO:0033198) | 2.22760198 |
| 132 | regulation of cardiac muscle cell differentiation (GO:2000725) | 2.22191431 |
| 133 | negative regulation of cell aging (GO:0090344) | 2.19847905 |
| 134 | auditory receptor cell stereocilium organization (GO:0060088) | 2.14996654 |
| 135 | response to peptidoglycan (GO:0032494) | 2.14881847 |
| 136 | inositol phosphate catabolic process (GO:0071545) | 2.12979585 |
| 137 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 2.11748946 |
| 138 | tryptophan metabolic process (GO:0006568) | 2.11311258 |
| 139 | protein K11-linked deubiquitination (GO:0035871) | 2.10116044 |
| 140 | fusion of sperm to egg plasma membrane (GO:0007342) | 2.08773057 |
| 141 | phosphatidylethanolamine metabolic process (GO:0046337) | 2.08452227 |
| 142 | sperm motility (GO:0030317) | 2.06478974 |
| 143 | negative regulation of organ growth (GO:0046621) | 2.06234637 |
| 144 | response to xenobiotic stimulus (GO:0009410) | 2.04912942 |
| 145 | amino sugar catabolic process (GO:0046348) | 2.04334410 |
| 146 | phosphatidylglycerol acyl-chain remodeling (GO:0036148) | 2.02093593 |
| 147 | negative regulation of interleukin-8 production (GO:0032717) | 2.01241738 |
| 148 | amine catabolic process (GO:0009310) | 2.00566902 |
| 149 | * regulation of rhodopsin mediated signaling pathway (GO:0022400) | 18.2849468 |
| 150 | * rhodopsin mediated signaling pathway (GO:0016056) | 17.7826666 |
| 151 | retinal cone cell development (GO:0046549) | 17.3538273 |
| 152 | vitamin A metabolic process (GO:0006776) | 15.3477525 |
| 153 | photoreceptor cell development (GO:0042461) | 12.6966214 |
| 154 | eye photoreceptor cell development (GO:0042462) | 12.2151649 |
| 155 | photoreceptor cell maintenance (GO:0045494) | 11.7702497 |
| 156 | detection of light stimulus involved in sensory perception (GO:0050962) | 11.6088914 |
| 157 | detection of light stimulus involved in visual perception (GO:0050908) | 11.6088914 |
| 158 | * phototransduction (GO:0007602) | 10.8781771 |
| 159 | cellular response to electrical stimulus (GO:0071257) | 10.8455735 |
| 160 | * phototransduction, visible light (GO:0007603) | 10.6220248 |
| 161 | * detection of light stimulus (GO:0009583) | 10.2903959 |
| 162 | protein-chromophore linkage (GO:0018298) | 10.1895828 |
| 163 | * detection of visible light (GO:0009584) | 10.1759503 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.21100583 |
| 2 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 4.44845654 |
| 3 | VDR_22108803_ChIP-Seq_LS180_Human | 4.18872727 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.40194791 |
| 5 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 3.29204645 |
| 6 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 2.53041603 |
| 7 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.50861706 |
| 8 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.38557364 |
| 9 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.15900272 |
| 10 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.08963371 |
| 11 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 2.04134864 |
| 12 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.92008470 |
| 13 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.87848170 |
| 14 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.83804033 |
| 15 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.82331440 |
| 16 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.81870768 |
| 17 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.79744374 |
| 18 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.78228524 |
| 19 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.69476606 |
| 20 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.68420510 |
| 21 | KDM2B_26808549_Chip-Seq_K562_Human | 1.67834455 |
| 22 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.66057028 |
| 23 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.66020783 |
| 24 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.63733984 |
| 25 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.62341909 |
| 26 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.61965174 |
| 27 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.60933290 |
| 28 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.60188715 |
| 29 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.59278236 |
| 30 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.56698747 |
| 31 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.56314812 |
| 32 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.55349476 |
| 33 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.54568013 |
| 34 | AR_19668381_ChIP-Seq_PC3_Human | 1.53746657 |
| 35 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.52716709 |
| 36 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.52437316 |
| 37 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.51517645 |
| 38 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.50295281 |
| 39 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.48524915 |
| 40 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.47294465 |
| 41 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.44443649 |
| 42 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.43575831 |
| 43 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.43081292 |
| 44 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.41575608 |
| 45 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.41012158 |
| 46 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.39840708 |
| 47 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.39361063 |
| 48 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.37686350 |
| 49 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.37474587 |
| 50 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.37419825 |
| 51 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.37191838 |
| 52 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.36239576 |
| 53 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 1.35883669 |
| 54 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.35410149 |
| 55 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.34904949 |
| 56 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.34468423 |
| 57 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.34420976 |
| 58 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.32268075 |
| 59 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.31799582 |
| 60 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.29167365 |
| 61 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.27945293 |
| 62 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.27945293 |
| 63 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.27251928 |
| 64 | TBL1_22424771_ChIP-Seq_293T_Human | 1.23707572 |
| 65 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.22953381 |
| 66 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.21152389 |
| 67 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.18649795 |
| 68 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.17748856 |
| 69 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.17662714 |
| 70 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.16839438 |
| 71 | * SMC4_20622854_ChIP-Seq_HELA_Human | 1.16448330 |
| 72 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.16445339 |
| 73 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.16109616 |
| 74 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.15286904 |
| 75 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.15056669 |
| 76 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.14669965 |
| 77 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.14669965 |
| 78 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.13970651 |
| 79 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.13925291 |
| 80 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.13364682 |
| 81 | EWS_26573619_Chip-Seq_HEK293_Human | 1.13069442 |
| 82 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.12398203 |
| 83 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.12046268 |
| 84 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.11686569 |
| 85 | NCOR_22424771_ChIP-Seq_293T_Human | 1.11497818 |
| 86 | WDR5_24793694_ChIP-Seq_LNCAP_Human | 1.11430432 |
| 87 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.11358853 |
| 88 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.11135722 |
| 89 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.09362204 |
| 90 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.08335640 |
| 91 | AR_25329375_ChIP-Seq_VCAP_Human | 1.07525428 |
| 92 | FUS_26573619_Chip-Seq_HEK293_Human | 1.07264298 |
| 93 | RXR_22108803_ChIP-Seq_LS180_Human | 1.07169763 |
| 94 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.05838724 |
| 95 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.05632840 |
| 96 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.05577049 |
| 97 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.05432650 |
| 98 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.05432650 |
| 99 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 1.05235605 |
| 100 | STAT3_23295773_ChIP-Seq_U87_Human | 1.05120811 |
| 101 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.04728136 |
| 102 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.04627035 |
| 103 | CBP_21632823_ChIP-Seq_H3396_Human | 1.04568509 |
| 104 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.03945646 |
| 105 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.03834706 |
| 106 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.02854064 |
| 107 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.02198212 |
| 108 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.02073264 |
| 109 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.01154722 |
| 110 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.99145732 |
| 111 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.98567880 |
| 112 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.98446443 |
| 113 | P68_20966046_ChIP-Seq_HELA_Human | 0.97846015 |
| 114 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.97475345 |
| 115 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.97164159 |
| 116 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.96497154 |
| 117 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.96349387 |
| 118 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.96007124 |
| 119 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.95856833 |
| 120 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.95418164 |
| 121 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.95006025 |
| 122 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.94960332 |
| 123 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.94580994 |
| 124 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.94286937 |
| 125 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.93982092 |
| 126 | P300_19829295_ChIP-Seq_ESCs_Human | 0.93866464 |
| 127 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.93691857 |
| 128 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.93521695 |
| 129 | CJUN_26792858_Chip-Seq_BT549_Human | 0.93364604 |
| 130 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.93161087 |
| 131 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.93041217 |
| 132 | KDM2B_26808549_Chip-Seq_REH_Human | 0.92680350 |
| 133 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.92300913 |
| 134 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.91811549 |
| 135 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.91636370 |
| 136 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.91593439 |
| 137 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.91259290 |
| 138 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.91122522 |
| 139 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.90917663 |
| 140 | GF1_26923725_Chip-Seq_HPCs_Mouse | 0.90375011 |
| 141 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.90331581 |
| 142 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.90053391 |
| 143 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.89837152 |
| 144 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.89634987 |
| 145 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.88879755 |
| 146 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.88673254 |
| 147 | * MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.88521308 |
| 148 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.88205159 |
| 149 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.88205159 |
| 150 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.87341244 |
| 151 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.86719403 |
| 152 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.86719403 |
| 153 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.86474360 |
| 154 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.86425272 |
| 155 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.86250912 |
| 156 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.85856069 |
| 157 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.84616466 |
| 158 | SMAD4_21741376_ChIP-Seq_ESCs_Human | 0.84472756 |
| 159 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.84416535 |
| 160 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.83538118 |
| 161 | TCF4_23295773_ChIP-Seq_U87_Human | 0.81759542 |
| 162 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.81110901 |
| 163 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.80728470 |
| 164 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.80341927 |
| 165 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.80144835 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * MP0005551_abnormal_eye_electrophysiolog | 9.76772848 |
| 2 | * MP0005253_abnormal_eye_physiology | 6.61396902 |
| 3 | MP0006072_abnormal_retinal_apoptosis | 6.58559264 |
| 4 | MP0003950_abnormal_plasma_membrane | 4.02327192 |
| 5 | MP0005195_abnormal_posterior_eye | 3.90817225 |
| 6 | MP0001324_abnormal_eye_pigmentation | 3.45043396 |
| 7 | * MP0005391_vision/eye_phenotype | 3.16707385 |
| 8 | MP0002090_abnormal_vision | 3.01677967 |
| 9 | MP0005423_abnormal_somatic_nervous | 2.91978401 |
| 10 | MP0002638_abnormal_pupillary_reflex | 2.80577002 |
| 11 | MP0002229_neurodegeneration | 2.59019429 |
| 12 | MP0001986_abnormal_taste_sensitivity | 2.56902374 |
| 13 | MP0005171_absent_coat_pigmentation | 2.19342799 |
| 14 | MP0001764_abnormal_homeostasis | 2.14726328 |
| 15 | MP0003011_delayed_dark_adaptation | 11.2153233 |
| 16 | MP0003136_yellow_coat_color | 1.97507070 |
| 17 | MP0002752_abnormal_somatic_nervous | 1.93314341 |
| 18 | MP0004019_abnormal_vitamin_homeostasis | 1.40101027 |
| 19 | MP0002882_abnormal_neuron_morphology | 1.38692767 |
| 20 | MP0002653_abnormal_ependyma_morphology | 1.34140531 |
| 21 | MP0005174_abnormal_tail_pigmentation | 1.23455130 |
| 22 | MP0005167_abnormal_blood-brain_barrier | 1.23251545 |
| 23 | MP0004233_abnormal_muscle_weight | 1.11789678 |
| 24 | MP0001984_abnormal_olfaction | 1.06140649 |
| 25 | MP0005410_abnormal_fertilization | 1.04481434 |
| 26 | MP0003724_increased_susceptibility_to | 1.02598260 |
| 27 | MP0005197_abnormal_uvea_morphology | 1.01963827 |
| 28 | MP0001502_abnormal_circadian_rhythm | 0.93784699 |
| 29 | MP0004885_abnormal_endolymph | 0.93015380 |
| 30 | MP0002736_abnormal_nociception_after | 0.92046662 |
| 31 | MP0003303_peritoneal_inflammation | 0.89470685 |
| 32 | MP0002127_abnormal_cardiovascular_syste | 0.88541682 |
| 33 | MP0002332_abnormal_exercise_endurance | 0.88489587 |
| 34 | MP0004270_analgesia | 0.85650089 |
| 35 | MP0009764_decreased_sensitivity_to | 0.84727513 |
| 36 | MP0002254_reproductive_system_inflammat | 0.78542131 |
| 37 | MP0005499_abnormal_olfactory_system | 0.78488994 |
| 38 | MP0005394_taste/olfaction_phenotype | 0.78488994 |
| 39 | MP0001486_abnormal_startle_reflex | 0.78200553 |
| 40 | MP0000569_abnormal_digit_pigmentation | 0.77690610 |
| 41 | MP0003634_abnormal_glial_cell | 0.77487780 |
| 42 | MP0002272_abnormal_nervous_system | 0.76488284 |
| 43 | MP0005187_abnormal_penis_morphology | 0.74973692 |
| 44 | MP0002102_abnormal_ear_morphology | 0.74634756 |
| 45 | MP0006054_spinal_hemorrhage | 0.73870216 |
| 46 | MP0006082_CNS_inflammation | 0.73691952 |
| 47 | MP0003172_abnormal_lysosome_physiology | 0.68791795 |
| 48 | MP0004381_abnormal_hair_follicle | 0.68467095 |
| 49 | MP0008789_abnormal_olfactory_epithelium | 0.64226993 |
| 50 | MP0001545_abnormal_hematopoietic_system | 0.61761514 |
| 51 | MP0005397_hematopoietic_system_phenotyp | 0.61761514 |
| 52 | MP0005058_abnormal_lysosome_morphology | 0.61351992 |
| 53 | MP0000516_abnormal_urinary_system | 0.60883358 |
| 54 | MP0005367_renal/urinary_system_phenotyp | 0.60883358 |
| 55 | MP0006292_abnormal_olfactory_placode | 0.60111156 |
| 56 | MP0002735_abnormal_chemical_nociception | 0.60050796 |
| 57 | MP0003075_altered_response_to | 0.57179710 |
| 58 | MP0003880_abnormal_central_pattern | 0.56706737 |
| 59 | MP0004859_abnormal_synaptic_plasticity | 0.55761679 |
| 60 | MP0002734_abnormal_mechanical_nocicepti | 0.55515577 |
| 61 | MP0000538_abnormal_urinary_bladder | 0.52511231 |
| 62 | MP0002148_abnormal_hypersensitivity_rea | 0.52479697 |
| 63 | MP0002064_seizures | 0.51995660 |
| 64 | MP0005376_homeostasis/metabolism_phenot | 0.49143935 |
| 65 | MP0001286_abnormal_eye_development | 0.48940175 |
| 66 | MP0001756_abnormal_urination | 0.48768611 |
| 67 | MP0005451_abnormal_body_composition | 0.47752806 |
| 68 | MP0000465_gastrointestinal_hemorrhage | 0.47693076 |
| 69 | MP0003635_abnormal_synaptic_transmissio | 0.47682938 |
| 70 | MP0001963_abnormal_hearing_physiology | 0.46379840 |
| 71 | MP0003878_abnormal_ear_physiology | 0.46376605 |
| 72 | MP0005377_hearing/vestibular/ear_phenot | 0.46376605 |
| 73 | MP0009046_muscle_twitch | 0.46084341 |
| 74 | MP0008004_abnormal_stomach_pH | 0.44746290 |
| 75 | MP0003045_fibrosis | 0.43843958 |
| 76 | MP0002837_dystrophic_cardiac_calcinosis | 0.43064500 |
| 77 | MP0002419_abnormal_innate_immunity | 0.42574340 |
| 78 | MP0000015_abnormal_ear_pigmentation | 0.41368600 |
| 79 | MP0002933_joint_inflammation | 0.41296566 |
| 80 | MP0001835_abnormal_antigen_presentation | 0.41202266 |
| 81 | MP0002063_abnormal_learning/memory/cond | 0.39792176 |
| 82 | MP0002572_abnormal_emotion/affect_behav | 0.39576624 |
| 83 | MP0004145_abnormal_muscle_electrophysio | 0.38890883 |
| 84 | MP0002067_abnormal_sensory_capabilities | 0.38195594 |
| 85 | MP0004215_abnormal_myocardial_fiber | 0.37300428 |
| 86 | MP0009745_abnormal_behavioral_response | 0.36448666 |
| 87 | MP0003436_decreased_susceptibility_to | 0.36031511 |
| 88 | MP0001968_abnormal_touch/_nociception | 0.35838054 |
| 89 | MP0000343_altered_response_to | 0.35277442 |
| 90 | MP0004924_abnormal_behavior | 0.34272829 |
| 91 | MP0005386_behavior/neurological_phenoty | 0.34272829 |
| 92 | MP0005000_abnormal_immune_tolerance | 0.34196897 |
| 93 | MP0008877_abnormal_DNA_methylation | 0.34181189 |
| 94 | MP0005620_abnormal_muscle_contractility | 0.33550866 |
| 95 | MP0004484_altered_response_of | 0.32745738 |
| 96 | MP0004085_abnormal_heartbeat | 0.32620331 |
| 97 | MP0004782_abnormal_surfactant_physiolog | 0.32214842 |
| 98 | MP0008775_abnormal_heart_ventricle | 0.31955440 |
| 99 | MP0003300_gastrointestinal_ulcer | 0.31782502 |
| 100 | MP0005670_abnormal_white_adipose | 0.31693231 |
| 101 | MP0000372_irregular_coat_pigmentation | 0.30132960 |
| 102 | MP0001800_abnormal_humoral_immune | 0.30039971 |
| 103 | MP0002452_abnormal_antigen_presenting | 0.29470964 |
| 104 | MP0002282_abnormal_trachea_morphology | 0.29397517 |
| 105 | MP0001905_abnormal_dopamine_level | 0.29298180 |
| 106 | MP0002733_abnormal_thermal_nociception | 0.29188043 |
| 107 | MP0005595_abnormal_vascular_smooth | 0.29058273 |
| 108 | MP0004142_abnormal_muscle_tone | 0.28568599 |
| 109 | MP0001879_abnormal_lymphatic_vessel | 0.28389596 |
| 110 | MP0005671_abnormal_response_to | 0.28381483 |
| 111 | MP0000685_abnormal_immune_system | 0.27896145 |
| 112 | MP0002075_abnormal_coat/hair_pigmentati | 0.27889901 |
| 113 | MP0005365_abnormal_bile_salt | 0.27432950 |
| 114 | MP0005535_abnormal_body_temperature | 0.27160700 |
| 115 | MP0001790_abnormal_immune_system | 0.26742032 |
| 116 | MP0005387_immune_system_phenotype | 0.26742032 |
| 117 | MP0001661_extended_life_span | 0.26451024 |
| 118 | MP0002723_abnormal_immune_serum | 0.25972003 |
| 119 | MP0005076_abnormal_cell_differentiation | 0.25546251 |
| 120 | MP0004043_abnormal_pH_regulation | 0.25540730 |
| 121 | MP0003698_abnormal_male_reproductive | 0.25301144 |
| 122 | MP0000631_abnormal_neuroendocrine_gland | 0.25222843 |
| 123 | MP0005310_abnormal_salivary_gland | 0.24927710 |
| 124 | MP0003646_muscle_fatigue | 0.24229437 |
| 125 | MP0001533_abnormal_skeleton_physiology | 0.24018054 |
| 126 | MP0004742_abnormal_vestibular_system | 0.23606213 |
| 127 | MP0003252_abnormal_bile_duct | 0.22838767 |
| 128 | MP0000026_abnormal_inner_ear | 0.22760320 |
| 129 | MP0003638_abnormal_response/metabolism_ | 0.22465043 |
| 130 | MP0005165_increased_susceptibility_to | 0.22450218 |
| 131 | MP0008569_lethality_at_weaning | 0.22232691 |
| 132 | MP0003787_abnormal_imprinting | 0.21296790 |
| 133 | MP0000751_myopathy | 0.21160277 |
| 134 | MP0002108_abnormal_muscle_morphology | 0.19907752 |
| 135 | MP0009780_abnormal_chondrocyte_physiolo | 0.19849186 |
| 136 | MP0002066_abnormal_motor_capabilities/c | 0.19630901 |
| 137 | MP0002152_abnormal_brain_morphology | 0.18961414 |
| 138 | MP0010386_abnormal_urinary_bladder | 0.18432098 |
| 139 | MP0004811_abnormal_neuron_physiology | 0.18175682 |
| 140 | MP0002928_abnormal_bile_duct | 0.17561277 |
| 141 | MP0005193_abnormal_anterior_eye | 0.17461126 |
| 142 | MP0001915_intracranial_hemorrhage | 0.17318973 |
| 143 | MP0005330_cardiomyopathy | 0.15624692 |
| 144 | MP0003632_abnormal_nervous_system | 0.12857260 |
| 145 | MP0005248_abnormal_Harderian_gland | 0.12791197 |
| 146 | MP0002184_abnormal_innervation | 0.12126026 |
| 147 | MP0003943_abnormal_hepatobiliary_system | 0.11337238 |
| 148 | MP0002697_abnormal_eye_size | 0.11161085 |
| 149 | MP0003890_abnormal_embryonic-extraembry | 0.11056234 |
| 150 | MP0000230_abnormal_systemic_arterial | 0.10706098 |
| 151 | MP0003633_abnormal_nervous_system | 0.10467709 |
| 152 | MP0000749_muscle_degeneration | 0.10435180 |
| 153 | MP0005084_abnormal_gallbladder_morpholo | 0.10391314 |
| 154 | MP0005646_abnormal_pituitary_gland | 0.10278178 |
| 155 | MP0001614_abnormal_blood_vessel | 0.09595718 |
| 156 | MP0001501_abnormal_sleep_pattern | 0.09435871 |
| 157 | MP0002557_abnormal_social/conspecific_i | 0.08639193 |
| 158 | MP0001970_abnormal_pain_threshold | 0.08413539 |
| 159 | MP0008875_abnormal_xenobiotic_pharmacok | 0.08319125 |
| 160 | MP0005266_abnormal_metabolism | 0.08138156 |
| 161 | MP0002909_abnormal_adrenal_gland | 0.07792344 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Dyschromatopsia (HP:0007641) | 9.66382462 |
| 2 | Pigmentary retinal degeneration (HP:0001146) | 9.61272556 |
| 3 | Chorioretinal atrophy (HP:0000533) | 8.31168822 |
| 4 | Central scotoma (HP:0000603) | 8.00525495 |
| 5 | Abnormality of macular pigmentation (HP:0008002) | 7.87844493 |
| 6 | Attenuation of retinal blood vessels (HP:0007843) | 7.74644149 |
| 7 | Pendular nystagmus (HP:0012043) | 7.52925386 |
| 8 | Scotoma (HP:0000575) | 7.19762865 |
| 9 | Decreased central vision (HP:0007663) | 6.49034051 |
| 10 | Abolished electroretinogram (ERG) (HP:0000550) | 6.41940138 |
| 11 | Photophobia (HP:0000613) | 5.84480822 |
| 12 | Type II diabetes mellitus (HP:0005978) | 5.72572915 |
| 13 | Vitreoretinal degeneration (HP:0000655) | 5.45137627 |
| 14 | Macular degeneration (HP:0000608) | 5.17041031 |
| 15 | Increased corneal curvature (HP:0100692) | 4.70214778 |
| 16 | Keratoconus (HP:0000563) | 4.70214778 |
| 17 | Choroideremia (HP:0001139) | 4.67402543 |
| 18 | Severe visual impairment (HP:0001141) | 4.47826804 |
| 19 | Retinitis pigmentosa (HP:0000510) | 4.45486269 |
| 20 | Cone-rod dystrophy (HP:0000548) | 4.43647697 |
| 21 | Posterior subcapsular cataract (HP:0007787) | 4.42679674 |
| 22 | Constricted visual fields (HP:0001133) | 4.08738542 |
| 23 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 3.72649412 |
| 24 | Systemic lupus erythematosus (HP:0002725) | 3.24049036 |
| 25 | Progressive visual loss (HP:0000529) | 3.04760662 |
| 26 | Retinal atrophy (HP:0001105) | 2.95662610 |
| 27 | Optic disc pallor (HP:0000543) | 2.71810948 |
| 28 | Subcapsular cataract (HP:0000523) | 2.67332756 |
| 29 | Congenital sensorineural hearing impairment (HP:0008527) | 2.58333065 |
| 30 | Wide nasal bridge (HP:0000431) | 2.55853314 |
| 31 | Mesangial abnormality (HP:0001966) | 2.46658235 |
| 32 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.39315349 |
| 33 | Gait imbalance (HP:0002141) | 2.37861426 |
| 34 | Congenital primary aphakia (HP:0007707) | 2.35645501 |
| 35 | Glomerulonephritis (HP:0000099) | 2.30984597 |
| 36 | Mutism (HP:0002300) | 2.22480198 |
| 37 | Action tremor (HP:0002345) | 2.14827532 |
| 38 | Ulnar claw (HP:0001178) | 2.13676588 |
| 39 | Nephrogenic diabetes insipidus (HP:0009806) | 2.07679250 |
| 40 | Medial flaring of the eyebrow (HP:0010747) | 2.00527682 |
| 41 | Congenital stationary night blindness (HP:0007642) | 15.6958514 |
| 42 | Bony spicule pigmentary retinopathy (HP:0007737) | 11.7335976 |
| 43 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 10.6148508 |
| 44 | Abnormal rod and cone electroretinograms (HP:0008323) | 10.1693641 |
| 45 | Complement deficiency (HP:0004431) | 1.99810584 |
| 46 | Thyroiditis (HP:0100646) | 1.98844206 |
| 47 | Poor coordination (HP:0002370) | 1.79341392 |
| 48 | Akinesia (HP:0002304) | 1.77056146 |
| 49 | Disinhibition (HP:0000734) | 1.75144027 |
| 50 | Increased cerebral lipofuscin (HP:0011813) | 1.75025345 |
| 51 | Hemorrhage of the eye (HP:0011885) | 1.72152450 |
| 52 | Hyperventilation (HP:0002883) | 1.69723765 |
| 53 | Optic atrophy (HP:0000648) | 1.63654065 |
| 54 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.63073777 |
| 55 | Interstitial pulmonary disease (HP:0006530) | 1.62520919 |
| 56 | Vaginal atresia (HP:0000148) | 1.62150822 |
| 57 | Absent speech (HP:0001344) | 1.61084428 |
| 58 | Peripheral hypomyelination (HP:0007182) | 1.60284797 |
| 59 | Horizontal nystagmus (HP:0000666) | 1.56178115 |
| 60 | Abnormality of the costochondral junction (HP:0000919) | 1.55603069 |
| 61 | Amyloidosis (HP:0011034) | 1.55183753 |
| 62 | Genital tract atresia (HP:0001827) | 1.55021403 |
| 63 | Hematochezia (HP:0002573) | 1.54917781 |
| 64 | Abnormality of glycolipid metabolism (HP:0010969) | 1.53331789 |
| 65 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.53331789 |
| 66 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.53331789 |
| 67 | Nephritis (HP:0000123) | 1.52734713 |
| 68 | Fetal akinesia sequence (HP:0001989) | 1.51937663 |
| 69 | Annular pancreas (HP:0001734) | 1.51915886 |
| 70 | Abnormal albumin level (HP:0012116) | 1.50943926 |
| 71 | Hypoalbuminemia (HP:0003073) | 1.50943926 |
| 72 | Enlarged epiphyses (HP:0010580) | 1.46041007 |
| 73 | Abnormal drinking behavior (HP:0030082) | 1.45726714 |
| 74 | Polydipsia (HP:0001959) | 1.45726714 |
| 75 | Polar cataract (HP:0010696) | 1.45106912 |
| 76 | Vacuolated lymphocytes (HP:0001922) | 1.43947011 |
| 77 | Metaphyseal irregularity (HP:0003025) | 1.39216597 |
| 78 | True hermaphroditism (HP:0010459) | 1.38888726 |
| 79 | Long clavicles (HP:0000890) | 1.37384483 |
| 80 | Agnosia (HP:0010524) | 1.37323645 |
| 81 | Zonular cataract (HP:0010920) | 1.36567674 |
| 82 | Abnormality of complement system (HP:0005339) | 1.35849071 |
| 83 | Severe Myopia (HP:0011003) | 1.35579043 |
| 84 | Coronal craniosynostosis (HP:0004440) | 1.35323100 |
| 85 | Tubular atrophy (HP:0000092) | 1.34520561 |
| 86 | Abnormal pupillary function (HP:0007686) | 1.33259042 |
| 87 | Dysostosis multiplex (HP:0000943) | 1.32414237 |
| 88 | White forelock (HP:0002211) | 1.32341615 |
| 89 | Dysdiadochokinesis (HP:0002075) | 1.31602723 |
| 90 | Increased CSF protein (HP:0002922) | 1.30984699 |
| 91 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.30881898 |
| 92 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.25482397 |
| 93 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.25482397 |
| 94 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.25482397 |
| 95 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.25139440 |
| 96 | Axonal loss (HP:0003447) | 1.24972383 |
| 97 | Joint hemorrhage (HP:0005261) | 1.24761315 |
| 98 | Abnormality of the hepatic vasculature (HP:0006707) | 1.23860310 |
| 99 | Hypoplastic pelvis (HP:0008839) | 1.23329937 |
| 100 | Delayed epiphyseal ossification (HP:0002663) | 1.22892319 |
| 101 | Albinism (HP:0001022) | 1.22757182 |
| 102 | Rib fusion (HP:0000902) | 1.20720026 |
| 103 | Hypopigmentation of the fundus (HP:0007894) | 1.20703681 |
| 104 | Facial diplegia (HP:0001349) | 1.19739196 |
| 105 | Poor head control (HP:0002421) | 1.19349310 |
| 106 | Retinal detachment (HP:0000541) | 1.19319267 |
| 107 | Stomatitis (HP:0010280) | 1.18510683 |
| 108 | Hypoplastic iliac wings (HP:0002866) | 1.16669521 |
| 109 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 1.16434318 |
| 110 | Widely patent fontanelles and sutures (HP:0004492) | 1.15505830 |
| 111 | Dyskinesia (HP:0100660) | 1.13670794 |
| 112 | Recurrent abscess formation (HP:0002722) | 1.13427696 |
| 113 | Epileptic encephalopathy (HP:0200134) | 1.11180760 |
| 114 | Pancreatic fibrosis (HP:0100732) | 1.08615320 |
| 115 | Astigmatism (HP:0000483) | 1.03748322 |
| 116 | Abnormality of the fovea (HP:0000493) | 1.03191154 |
| 117 | Broad foot (HP:0001769) | 0.99482165 |
| 118 | Cerebellar dysplasia (HP:0007033) | 0.99296448 |
| 119 | Left ventricular hypertrophy (HP:0001712) | 0.98729332 |
| 120 | Hypoplasia of the fovea (HP:0007750) | 0.97773719 |
| 121 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 0.97773719 |
| 122 | Recurrent sinusitis (HP:0011108) | 0.97722167 |
| 123 | Specific learning disability (HP:0001328) | 0.96642548 |
| 124 | Truncal ataxia (HP:0002078) | 0.95074942 |
| 125 | Febrile seizures (HP:0002373) | 0.94666935 |
| 126 | Decreased testicular size (HP:0008734) | 0.92082471 |
| 127 | Cystic liver disease (HP:0006706) | 0.91478956 |
| 128 | Progressive cerebellar ataxia (HP:0002073) | 0.88982882 |
| 129 | Asthma (HP:0002099) | 0.87807608 |
| 130 | Pancreatic cysts (HP:0001737) | 0.84933576 |
| 131 | Chorioretinal coloboma (HP:0000567) | 0.83128494 |
| 132 | Visual hallucinations (HP:0002367) | 0.82557503 |
| 133 | Hypermetropia (HP:0000540) | 0.77935569 |
| 134 | Aplasia/Hypoplasia of the macula (HP:0008059) | 0.76870334 |
| 135 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 0.76224652 |
| 136 | Partial agenesis of the corpus callosum (HP:0001338) | 0.74642569 |
| 137 | Abnormality of dental color (HP:0011073) | 0.73946138 |
| 138 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 0.73911156 |
| 139 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 0.70640795 |
| 140 | Sclerocornea (HP:0000647) | 0.70593883 |
| 141 | Prolonged QT interval (HP:0001657) | 0.68794655 |
| 142 | Abnormality of midbrain morphology (HP:0002418) | 0.66178060 |
| 143 | Molar tooth sign on MRI (HP:0002419) | 0.66178060 |
| 144 | Dental crowding (HP:0000678) | 0.65537331 |
| 145 | Lymphopenia (HP:0001888) | 0.65364170 |
| 146 | Genetic anticipation (HP:0003743) | 0.64835690 |
| 147 | Furrowed tongue (HP:0000221) | 0.64330467 |
| 148 | Hypodontia (HP:0000668) | 0.63080446 |
| 149 | Short foot (HP:0001773) | 0.62884248 |
| 150 | Postaxial hand polydactyly (HP:0001162) | 0.60433693 |
| 151 | Aqueductal stenosis (HP:0002410) | 0.59596473 |
| 152 | Chronic hepatic failure (HP:0100626) | 0.59308568 |
| 153 | Broad-based gait (HP:0002136) | 0.58628503 |
| 154 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 0.58527589 |
| 155 | Hypoventilation (HP:0002791) | 0.56852559 |
| 156 | Heterotopia (HP:0002282) | 0.56417786 |
| 157 | Polycystic ovaries (HP:0000147) | 0.56387295 |
| 158 | Macroorchidism (HP:0000053) | 0.55434773 |
| 159 | Generalized myoclonic seizures (HP:0002123) | 0.55073759 |
| 160 | Abnormal EKG (HP:0003115) | 0.54958620 |
| 161 | Nephrotic syndrome (HP:0000100) | 0.54298307 |
| 162 | Hirsutism (HP:0001007) | 0.53959002 |
| 163 | Abnormality of the parathyroid morphology (HP:0011766) | 0.53657318 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PBK | 7.66815169 |
| 2 | ACVR1B | 3.15498599 |
| 3 | PINK1 | 2.74426291 |
| 4 | WNK3 | 2.48918339 |
| 5 | BLK | 2.27856970 |
| 6 | IRAK2 | 2.19430287 |
| 7 | MAPK15 | 2.10659380 |
| 8 | GRK1 | 11.2493832 |
| 9 | INSRR | 1.85391398 |
| 10 | CCNB1 | 1.78155967 |
| 11 | ADRBK2 | 1.77765743 |
| 12 | ADRBK1 | 1.74912627 |
| 13 | STK38L | 1.73174921 |
| 14 | TGFBR2 | 1.69149122 |
| 15 | MAPK7 | 1.59477589 |
| 16 | TGFBR1 | 1.47825917 |
| 17 | CAMK1G | 1.47217219 |
| 18 | TAOK3 | 1.44968960 |
| 19 | SIK2 | 1.44968189 |
| 20 | RPS6KA4 | 1.40679841 |
| 21 | MAP4K2 | 1.40307331 |
| 22 | MUSK | 1.39101888 |
| 23 | NUAK1 | 1.37985502 |
| 24 | PIK3CG | 1.36795612 |
| 25 | ICK | 1.34725731 |
| 26 | CAMK1D | 1.27270577 |
| 27 | MAPK12 | 1.26016308 |
| 28 | CAMKK2 | 1.25039198 |
| 29 | BMPR1B | 1.24761626 |
| 30 | STK38 | 1.21350009 |
| 31 | CDK12 | 1.19947966 |
| 32 | MARK3 | 1.19887935 |
| 33 | STK39 | 1.12873007 |
| 34 | BRD4 | 1.11066932 |
| 35 | MAP3K10 | 1.10944507 |
| 36 | HIPK2 | 1.10779486 |
| 37 | MARK1 | 1.10145755 |
| 38 | IKBKB | 1.07721300 |
| 39 | PRKCZ | 1.07153137 |
| 40 | PAK6 | 1.04652912 |
| 41 | SGK223 | 1.04353251 |
| 42 | SGK494 | 1.04353251 |
| 43 | CSNK1D | 1.02673074 |
| 44 | NEK1 | 0.99760391 |
| 45 | PTK2B | 0.99187461 |
| 46 | MAP3K4 | 0.98626040 |
| 47 | GRK7 | 0.97442054 |
| 48 | PNCK | 0.96264120 |
| 49 | TNK2 | 0.94943819 |
| 50 | TNIK | 0.91606131 |
| 51 | OXSR1 | 0.90480017 |
| 52 | CSK | 0.90443222 |
| 53 | TRPM7 | 0.89214581 |
| 54 | PRKD3 | 0.86856986 |
| 55 | PRKCH | 0.85985602 |
| 56 | TXK | 0.84570328 |
| 57 | NLK | 0.84207991 |
| 58 | OBSCN | 0.82830024 |
| 59 | MYLK | 0.82496606 |
| 60 | CDK3 | 0.82082324 |
| 61 | TTK | 0.79526583 |
| 62 | ZAK | 0.79094726 |
| 63 | PHKG2 | 0.77705236 |
| 64 | PHKG1 | 0.77705236 |
| 65 | ERBB2 | 0.75647970 |
| 66 | CAMKK1 | 0.75398553 |
| 67 | SYK | 0.74768642 |
| 68 | SGK2 | 0.74215850 |
| 69 | MAP2K3 | 0.72858942 |
| 70 | FGFR2 | 0.72823484 |
| 71 | WNK1 | 0.71723103 |
| 72 | EIF2AK3 | 0.70231415 |
| 73 | NEK2 | 0.69717419 |
| 74 | AKT3 | 0.67823571 |
| 75 | SGK3 | 0.66205006 |
| 76 | PRKACG | 0.65783941 |
| 77 | PRKCB | 0.64694160 |
| 78 | BMPR2 | 0.64493855 |
| 79 | PRKAA1 | 0.64200820 |
| 80 | DDR2 | 0.64135195 |
| 81 | TEC | 0.62919739 |
| 82 | CAMK2D | 0.62800434 |
| 83 | IRAK1 | 0.62317370 |
| 84 | GRK5 | 0.61630531 |
| 85 | DYRK1A | 0.60921035 |
| 86 | LYN | 0.60674914 |
| 87 | FES | 0.59256117 |
| 88 | DAPK2 | 0.57743022 |
| 89 | TRIM28 | 0.56767023 |
| 90 | MAPKAPK3 | 0.56683685 |
| 91 | LATS1 | 0.55995871 |
| 92 | RPS6KA3 | 0.55978231 |
| 93 | PIM2 | 0.54915756 |
| 94 | PRKAA2 | 0.53889429 |
| 95 | PRKCQ | 0.53756967 |
| 96 | MAPK13 | 0.53669164 |
| 97 | NEK6 | 0.51768579 |
| 98 | KIT | 0.51338287 |
| 99 | PLK4 | 0.50606881 |
| 100 | FER | 0.50573819 |
| 101 | PLK2 | 0.50308239 |
| 102 | STK3 | 0.49200015 |
| 103 | CSF1R | 0.48521219 |
| 104 | TTN | 0.48031688 |
| 105 | TIE1 | 0.47654812 |
| 106 | CAMK1 | 0.46582868 |
| 107 | AKT2 | 0.45144878 |
| 108 | BTK | 0.45056092 |
| 109 | RIPK4 | 0.44356035 |
| 110 | CAMK2A | 0.44105319 |
| 111 | PRKDC | 0.43099318 |
| 112 | ZAP70 | 0.42085220 |
| 113 | DYRK1B | 0.41851559 |
| 114 | MAP3K14 | 0.41626848 |
| 115 | SCYL2 | 0.41453498 |
| 116 | CDK5 | 0.41148309 |
| 117 | SGK1 | 0.41065404 |
| 118 | TBK1 | 0.40628505 |
| 119 | PRKD2 | 0.39163398 |
| 120 | CSNK1G1 | 0.38700541 |
| 121 | PRKCE | 0.38439545 |
| 122 | PRKCG | 0.38414046 |
| 123 | MAP3K3 | 0.38240233 |
| 124 | GSK3B | 0.37829519 |
| 125 | MAPK9 | 0.37512977 |
| 126 | ABL1 | 0.36974483 |
| 127 | IRAK4 | 0.36618007 |
| 128 | DYRK2 | 0.36286135 |
| 129 | PRKG1 | 0.35927800 |
| 130 | MAP2K7 | 0.35542738 |
| 131 | MAP3K7 | 0.34727490 |
| 132 | RPS6KA5 | 0.34604002 |
| 133 | STK11 | 0.34448174 |
| 134 | MAPK14 | 0.33935690 |
| 135 | NTRK3 | 0.33617103 |
| 136 | HCK | 0.33534585 |
| 137 | MATK | 0.33447479 |
| 138 | TYK2 | 0.33445045 |
| 139 | PDGFRB | 0.33344849 |
| 140 | CSNK1G2 | 0.33274587 |
| 141 | PRKACA | 0.33094278 |
| 142 | EPHB2 | 0.32772091 |
| 143 | MAPK10 | 0.32183145 |
| 144 | CHEK2 | 0.32106418 |
| 145 | PLK3 | 0.31687966 |
| 146 | MINK1 | 0.31660518 |
| 147 | ERN1 | 0.31577917 |
| 148 | CAMK4 | 0.31375431 |
| 149 | JAK1 | 0.30924523 |
| 150 | IKBKE | 0.30490993 |
| 151 | SIK3 | 0.30004548 |
| 152 | CDK9 | 0.29454231 |
| 153 | ROCK1 | 0.29387032 |
| 154 | CSNK1G3 | 0.29060254 |
| 155 | ABL2 | 0.28925219 |
| 156 | RPS6KB1 | 0.28203970 |
| 157 | PRKCA | 0.27688124 |
| 158 | MAP2K4 | 0.27279127 |
| 159 | CDK1 | 0.25316410 |
| 160 | SIK1 | 0.25162291 |
| 161 | FRK | 0.22206223 |
| 162 | CSNK1E | 0.20461026 |
| 163 | PDK2 | 0.19606662 |
| 164 | PKN1 | 0.19315739 |
| 165 | ALK | 0.19000327 |
| 166 | MAPK3 | 0.18254228 |
| 167 | RPS6KB2 | 0.18026928 |
| 168 | MAPK8 | 0.16064263 |
| 169 | WNK4 | 0.15705768 |
| 170 | SRC | 0.14758949 |
| 171 | YES1 | 0.14209871 |
| 172 | CHEK1 | 0.14111902 |
| 173 | CDC42BPA | 0.13733272 |
| 174 | CDK15 | 0.12606209 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.25007493 |
| 2 | * Phototransduction_Homo sapiens_hsa04744 | 16.0325453 |
| 3 | Asthma_Homo sapiens_hsa05310 | 1.82154367 |
| 4 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.75158838 |
| 5 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.73561338 |
| 6 | Lysosome_Homo sapiens_hsa04142 | 1.65816722 |
| 7 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.55131856 |
| 8 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.49315103 |
| 9 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.45365399 |
| 10 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.44066353 |
| 11 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.43916429 |
| 12 | Olfactory transduction_Homo sapiens_hsa04740 | 1.43487022 |
| 13 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.36622018 |
| 14 | Other glycan degradation_Homo sapiens_hsa00511 | 1.31396177 |
| 15 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.26380609 |
| 16 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.23289906 |
| 17 | Pertussis_Homo sapiens_hsa05133 | 1.19106235 |
| 18 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.17055818 |
| 19 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.16360888 |
| 20 | Allograft rejection_Homo sapiens_hsa05330 | 1.15385550 |
| 21 | GABAergic synapse_Homo sapiens_hsa04727 | 1.14909924 |
| 22 | Tuberculosis_Homo sapiens_hsa05152 | 1.09573927 |
| 23 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.05540693 |
| 24 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.04317140 |
| 25 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.00165679 |
| 26 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.98674745 |
| 27 | Leishmaniasis_Homo sapiens_hsa05140 | 0.96681265 |
| 28 | Retinol metabolism_Homo sapiens_hsa00830 | 0.93714439 |
| 29 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.92639774 |
| 30 | Sulfur relay system_Homo sapiens_hsa04122 | 0.92418656 |
| 31 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.92008618 |
| 32 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.91923651 |
| 33 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.85893207 |
| 34 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.84291924 |
| 35 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.80861893 |
| 36 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.80369797 |
| 37 | Morphine addiction_Homo sapiens_hsa05032 | 0.78386947 |
| 38 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.76592861 |
| 39 | Circadian rhythm_Homo sapiens_hsa04710 | 0.75737800 |
| 40 | Circadian entrainment_Homo sapiens_hsa04713 | 0.75487267 |
| 41 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.74802427 |
| 42 | Malaria_Homo sapiens_hsa05144 | 0.73012962 |
| 43 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.71634865 |
| 44 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.70638888 |
| 45 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.67744153 |
| 46 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.62463655 |
| 47 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.62007305 |
| 48 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.60026568 |
| 49 | ABC transporters_Homo sapiens_hsa02010 | 0.59231573 |
| 50 | Legionellosis_Homo sapiens_hsa05134 | 0.59182451 |
| 51 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.57952391 |
| 52 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.57497005 |
| 53 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.54644037 |
| 54 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.52920385 |
| 55 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.51816958 |
| 56 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.51254887 |
| 57 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.51162895 |
| 58 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.51099153 |
| 59 | Insulin secretion_Homo sapiens_hsa04911 | 0.49595749 |
| 60 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.48101165 |
| 61 | Nicotine addiction_Homo sapiens_hsa05033 | 0.47725927 |
| 62 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.47189634 |
| 63 | Purine metabolism_Homo sapiens_hsa00230 | 0.45765813 |
| 64 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.44943352 |
| 65 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.44454953 |
| 66 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.43994170 |
| 67 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.43120201 |
| 68 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.41945509 |
| 69 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.41191235 |
| 70 | Phagosome_Homo sapiens_hsa04145 | 0.40987242 |
| 71 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.39891794 |
| 72 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.39419570 |
| 73 | Viral myocarditis_Homo sapiens_hsa05416 | 0.39133619 |
| 74 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.38086221 |
| 75 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.36586464 |
| 76 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.36480894 |
| 77 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.34985612 |
| 78 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.34561803 |
| 79 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.34418846 |
| 80 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.34410371 |
| 81 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.34212520 |
| 82 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.33557015 |
| 83 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.33510785 |
| 84 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.33354884 |
| 85 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.32984870 |
| 86 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.32336648 |
| 87 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.32051456 |
| 88 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.31716363 |
| 89 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.30151886 |
| 90 | Renin secretion_Homo sapiens_hsa04924 | 0.29167362 |
| 91 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.29040361 |
| 92 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.28996250 |
| 93 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.28852744 |
| 94 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.28510169 |
| 95 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.27667555 |
| 96 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.27655215 |
| 97 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.27636791 |
| 98 | Salivary secretion_Homo sapiens_hsa04970 | 0.27523920 |
| 99 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.27175742 |
| 100 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.27120095 |
| 101 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.26722533 |
| 102 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.25815541 |
| 103 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.25681146 |
| 104 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.25610001 |
| 105 | Platelet activation_Homo sapiens_hsa04611 | 0.25059391 |
| 106 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.25026766 |
| 107 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.24813190 |
| 108 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.24233288 |
| 109 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.23810627 |
| 110 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.23141931 |
| 111 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.22732944 |
| 112 | Long-term depression_Homo sapiens_hsa04730 | 0.22732494 |
| 113 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.22280065 |
| 114 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.21854274 |
| 115 | Cocaine addiction_Homo sapiens_hsa05030 | 0.21782110 |
| 116 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.21777465 |
| 117 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.21604301 |
| 118 | Long-term potentiation_Homo sapiens_hsa04720 | 0.20716564 |
| 119 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.20570991 |
| 120 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.20142378 |
| 121 | Galactose metabolism_Homo sapiens_hsa00052 | 0.17706821 |
| 122 | Alcoholism_Homo sapiens_hsa05034 | 0.17522999 |
| 123 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.17377399 |
| 124 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.16981657 |
| 125 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.16003827 |
| 126 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.15503565 |
| 127 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.15182933 |
| 128 | Lysine degradation_Homo sapiens_hsa00310 | 0.14989692 |
| 129 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.14770415 |
| 130 | Bile secretion_Homo sapiens_hsa04976 | 0.14548714 |
| 131 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.14267003 |
| 132 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.13247102 |
| 133 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.11123815 |
| 134 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.09770587 |
| 135 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.09082670 |
| 136 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.07938570 |
| 137 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.07699536 |
| 138 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.07467151 |
| 139 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.07311374 |
| 140 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.06644708 |
| 141 | Tight junction_Homo sapiens_hsa04530 | 0.06576252 |
| 142 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.06387227 |
| 143 | Insulin resistance_Homo sapiens_hsa04931 | 0.06382014 |
| 144 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.05246750 |
| 145 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.05188451 |
| 146 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.05007933 |
| 147 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.04985859 |
| 148 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.04934530 |
| 149 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.04360821 |
| 150 | Taste transduction_Homo sapiens_hsa04742 | 0.04354235 |
| 151 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.04128733 |
| 152 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.03872044 |
| 153 | Mineral absorption_Homo sapiens_hsa04978 | 0.03196965 |
| 154 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.02959247 |
| 155 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.02469270 |
| 156 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.01967239 |
| 157 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.01573216 |
| 158 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.01482966 |
| 159 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.01195877 |
| 160 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.00896189 |
| 161 | Glioma_Homo sapiens_hsa05214 | 0.00319239 |
| 162 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | -0.0040782 |
| 163 | Endocytosis_Homo sapiens_hsa04144 | -0.0033879 |

